Survival after radical prostatectomy and radiotherapy for prostate cancer: A population-based study

Journal of the Canadian Urological Association

Volumn 3, Issue 1, 2009, Pages 13-21

  Jeldres, Claudio ^a   Suardi, Nazareno ^a   Perrotte, Paul ^a   Capitanio, Umberto ^a   Walz, Jochen ^a   Hutterer, Georg C ^a   Saad, Fred ^a   Valiquette, Luc ^a   Graefen, Markus ^b   Widmer, Hugues ^a   Karakiewicz, Pierre I ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Martini Clinic Prostate Cancer Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65749103756     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007;177:2106-2131 (Pubitemid 46726449)
2. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005;293:2095-2101 (Pubitemid 40617061)
3. Aus G, Abbou CC, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol 2005; 48:546-551
4. Alibhai SM, inaglie G, inam R, et al. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003;21:3318-3327 (Pubitemid 46606266)
5. Schwartz KL, Alibhai SM, Tomlinson G, et al. Continued undertreatment of older men with localized prostate cancer. Urology 2003;62:860-865
6. Kattan MW, Cowen ME, Miles BJ. A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med 1997;12:299-305.
7. Life tables, Canada, provinces and territories. Ottawa: Statistics Canada; 2006. Cat no 84-537-XIE.
8. Albertsen PC, Fryback DG, Storer BE, et al. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626-631
9. Charlson ME, Pompei P, Ales KL, et al. A New method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383
10. Hall WH, Jani AB, Ryu JK, et al. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 2005;8:22-30.
11. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993;32:382-387
12. Bubolz T, Wasson JH, Lu-Yao G, et al. Treatments for prostate cancer in older men: 1984-1997. Urology 2001;58:977-982
13. Fowler JE Jr, Terrell FL, Renfroe DL. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol 1996;156:1714-1718
14. Alibhai SM, Krahn MD, Cohen MM, et al. Is there age bias in the treatment of localized prostate carcnoma? Cancer 2004;100:72-81.
15. Harlan LC, Potosky A, Gilliland FD, et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J inatl Cancer Inst 2001;93:1864-1871
16. Yan Y, Carvalhal GF, Catalona WJ, et al. Primary treatment choices for men with clinically localized prostate carcnoma detected by screening. Cancer 2000;88:1122-1130
17. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000;283:3217-3222
18. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. in Engl J Med 2005;352:1977-1984 (Pubitemid 40638368)
19. Fowler JE Jr, Braswell inT, Pandey P, et al. Experience with radical prostatectomy and radiation therapy for localized prostate cancer at a Veterans Affairs Medical Center. J Urol 1995;153:1026-1031